INTRODUCTION
CYSTIC HBROSis (CF) is the most common autosomal recessive disease in the Caucasian population, affecting 1 in 3000 births each year (Boat et al, 1989) . Although multiple organs are affected in this disease, the most severe and life-threatening pathology occurs in the lung, resulting in the production of abnormally viscous mucus, poor mucociliary clearance, chronic bacterial infections, bronchiectasis, and eventually pulmonary failure and death. The molecular defect in CF was elucidated following the cloning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which encodes an epithelial chloride (CI") channel Riordan et al, 1989; . Respiratory complications in CF caused by the lack of CFFR-mediated Cl~ transport in epithelial cells of the lung are believed to be the result of abnormally thick mucus secretions, which lead to obstmctive lung disease and impaired mucociliary clearance of bacterial pathogens (Taussig, 1984; Boat et al, 1989) . Current pathophysiologic hypotheses that attempt to describe the mechanism(s) by which unusually thick mucus in CF leads to chronic bacterial infections are based primarily on the notion that CF respiratory epithelia have defective Cl~ secretion and elevated Na+ absorption (Frizzell et al, 1979; Boucher et al, 1986; Li et al, 1988; Widdicombe, 1991) . Studies elucidating the regulatory effects of CFTR on the amiloride-sensitive Na"*" channel (ENaC) have linked the elevated Na""" transport observed in CF with defective CFTR function (Stutts et al, 1995) . Additional regulatory functions of CFTR may include its ability to facilitate ATP transport in the regulation of another Cl~ channel (ORCC) (Schwiebert et al, 1995) . Although the exact mechanism(s) by which altered electtolyte transport in CF leads to chronic bacterial infection are unknown, recent studies demonstrating reduced bactericidal activity of CF airway secretions suggest that alterations in CF surface airway fluid NaCl concentration may create a favorable milieu for bacterial colonization .
In addition to the contribution of electtolyte transport, several other findings have suggested that primary defects in glycoprotein sulfation, sialylation, and/or glycosylation may also contribute to the predisposition of bacterial colonization in the CF lung (Zach, 1990; Prince, 1992; Sajjan et al, 1992; Govan et al, 1993) . Such fmdings are based on the notion that CFTR may also act as an intracellular Cl~ channel, which, together with an ATP-driven proton-pump, facilitates endosomal acidification (Barasch et al, 1991; Al-Awqati et al, 1992) . In CF epithelial cells, this defect is proposed to cause a shift in the intravesicular pH of Golgi compartments that, in turn, decreases the activity of modifying enzymes such as sialyltransferase (Barasch et al, 1991; Al-Awqati et al, 1992 ). An altemative hypothesis has recentiy been proposed by which CFTR functions as a ttansporter of sulfate donor molecules (PAPS) in Golgi compartments (Pasyk and Foskett, 1997) . This mechanism attempts to explain the increased sulfation of glycoproteins as due to an increase in the concentration of inttavesicular sulfate donors. Previous smdies have evaluated the extent of sialylation and sulfation in purified secreted mucin from CF patients (Roussel et al, 1975; Boat et al, 1976) , primary tissue explants (Boat et al, 1976; Cheng et al, 1981) , and human bronchial xenografts (Zhang et al, 1995) . These studies have demonsttated an increase in the extent of sulfation and a decrease in the level of sialylation witiiin large-molecular-weight purified mucin samples from CF as compared to non-CF.
The characterization of CFTR expression within human lung has provided the foundation for understanding what cellular sites may be pathophysiologically important targets for gene therapy of CF lung disease. Initial reports using polymerase chain reaction (PCR) analysis of human lung have demonsttated that, on average, only several copies of CFIR mRNA are present in lung epithelial cells (Trapnell et al, 1991) . Furthermore, variation in the splicing of CFTR ttanscripts within the CF population has suggested that as little as 8-15% of normal CFFR message is required for normal lung function (Chu et al, 1992; Rave-Harel et al, 1997) . Smdies localizing CFIR expression in the proximal human bronchus have demonstrated that CFTR protein and mRNA are expressed predominantiy in submucosal glands and to a lesser extent in the surface airway epithelium (Trezise and Buchwald, 1991; Engelhardt etal, 1992; Jacquot et al, 1993) . Human bronchial and distal surface airway epithelial cells express CFTR at high levels in an infrequent population of nonciliated cells (1-10%) (Engelhardt et al, 1992 . Although CFTR protein expression is undetectable in ciliated cells, altemative methods using inttacellular microelectrodes to measure apical membrane Cl~ permeabilities in freshly excised proximal airway tissues have suggested the CFIR is also expressed in ciliated cells at low levels (Cotton et al, 1987; Kunzelmann et al, 1995) . Additionally, the paradox regarding undetectable levels of CFTR gene expression in airway goblet cells, despite functional defects in mucous processing {i.e., sulfation and sialylation), suggests that CFTR may also function in these cell types at very low levels of expression. In summary, such findings demonsttate a highly regulated and compartmentalized expression of CFTR in the airway. This pattem of CFTR expression, which may be necessary for normal airway function, highlights the potential complexities associated with gene targeting to the CF lung.
Despite the lack of a concrete understanding of the pathophysiology of CF lung disease, gene therapy of CF has quickly become a paradigm for evaluating the safety and efficacy of gene ttansfer to the lung. To date, numerous phase I clinical tiials have been undertaken in an attempt to evaluate initial toxicity and efficacy using vehicles such as liposomes, recombinant adenovirus, and adeno-associated vims (Zabner et al, 1993; Boucher et al, 1994; Caplen etal, 1994 Caplen etal, , 1995 Crystal etal, 1994; O'Neal and Baudet, 1994; Sorscher etal, 1994; WUson et al, 1994; Knowles et al, 1995; Bellon et al, 1996; Hotte et al, 1996; McLachlan et al, 1996; Gill et al, 1997; Porteous et al, 1997) . The success of these clinical tiials for CF will largely be based on surrogate endpoints for evaluating tiie extent of functional complementation of primary CF defects. Many of tiiese sttidies have incorporated measures of functional complementation usmg die surrogate marker of ttansepiflielial potential difference to assess correction of Cr ttansport defects. In this study, we have evaluated an altemative functional endpoint (mucin sulfation) for assessing the efficacy of CFIR gene ttansfer in die lung.
The human bronchial xenograft model has proven valuable for evaluating CF primary defects in electtolyte and fluid transport (Goldman et al, 1995; Zhang et al, 1996) and mucous sulfation (Zhang et al, 1995) . The advantage of this model system includes the absence of bacterial infection and goblet cell hyperplasia, which can secondarily affect measurements of glycoprotein processing (Zhang etal, 1995) . Furthermore, because the lumen of these xenograft airways are readily assessable, this model provides the ability to smdy complementation of primary defects following gene ttansfer. Previous studies have demonstrated the utility of this model in studying gene transfer and complementation of Cl~ ttansport abnormalities following gene ttansfer with CFTR recombinant adenoviral vectors (Engelhardt et al, 1993 , Goldman et al, 1995 . In the present study, we have addressed the implications of diverse cellular targets for CF gene therapy in the airway by evaluating the efficacy of two independent vectors systems for correcting defects in C\' permeability and mucous sulfation.
MATERIALS AND METHODS

Generation of human bronchial xenografts
Primary CF cells used to generate human bronchial xenografts were isolated from CF bronchial tissue obtained from lung ttansplants. Cells were cultured as previously described (Zhang et al, 1995) for a period of 5-7 days prior to trypsinization for xenograft transplantation. "Open-ended" human bronchial xenografts were generated by previously described methodologies (Engelhardt and Wilson, 1996; Zhang et al, 1995 Zhang et al, ,1996 . Briefly, 1-2 X 10* cells were transplanted into denuded rat tracheas, ligated to flexible plastic tubing, and implanted into the flanks of athymic mice. Typically, grafts develop a fully differentiated epithelia with electrophysiologic characteristics of native CF tissue by 4 weeks post-ttansplantation (Goldman et al, 1995; Zhang et al, 1996) . In the present study, xenografts were used for functional studies of gene transfer between 5 and 6 weeks post-transplantation.
CFTR gene transfer into human bronchial xenografts
Two vector systems were evaluated for complementation of mucous sulfation defects, including recombinant adenovims and cationic liposomes. Recombinant CFFR (Ad.CMV PaCFTR) and alkaline phosphatase (Ad.CMV^sAlkphos) vectors were generated as previously described (Engelhardt et al, 1993; Goldman et al, 1995) . These constructs used the cytomegalovims (CMV) enhancer and )3-actin promoter to drive transgene expression. Vims was purified through two rounds of CsCl density centtifugation followed by desalting with gel filttation into a F12 medium prior to infection into fully differentiated xenografts. Infections were carried out by two protocols including a 16-hr single infection with 5 X 10'° pfu (which provided approximately 10% infection as assessed by ttansgene expression) or tittee sequential 16-hr infections every other day with 5 X 10'° pfu (which provided greater than 95% infection efficiencies). Adenovirally infected grafts were used for functional analysis 72 hr following the last infection. In conttast to recombinant adenoviral infections, cationic liposomemediated gene ttansfer was performed by a single ttansfection protocol using lipofectamine and two reporter plasmids, p/3aCFTR and pSV2Neo. These plasmids utilized the j8-actin and S V40 promoters to drive expression of CFIR and neomycin resistance genes, respectively. Because the level of ttansgene expression was below the level of histochemical reporter gene detection, the optimal DNA:lipid ratio was determined by assessing the level of transfection using ttansepithelial potential difference (PD). These studies, which are discussed below, measured the level of S-cpt-cAMP/Forskolin-inducible Cl~ permeability in CF xenografts ttansfected with p/SaCFTR. The optimal DNA:lipofectamine ratio was determined to be 90 /xg of plasmid DNA:60 /u,g of lipofectamine in a total of 100 pi of 5% dextrose. The iso-osmotic solution containing 5% dextrose was used because excessive salts caused precipitation of liposome:DNA mixtures.
Measurements of transepithelial potential difference
Transepithelial PD was used to assess the level of correction in cAMP-induced CI" permeability following ttansfection with liposomes and infection with recombinant adenovimses. Measurements of ttansepithelial PDs were perfonned as previously described (Zhang et al, 1996) usmg a continuous perfusion of the following sequence of buffers: (i) HEPES phosphatebuffered Ringer's solution (HPBR) containing 10 mM HEPES pH 7.4, 145 mM NaCl, 5 mM KCl, 1.2 mM MgS04, 1.2 mM Ca-gluconate, 2.4 mM K2HPO4, 0.4 mM KH2PO4; (ii) HPBR supplemented with 100 pM amiloride; (ui) HPBR (Cl~ free) containing 10 mM Hepes pH 7.4, 145 mM Na-gluconate, 5 mM K-gluconate, 1.2 mM MgS04, 1.2 mM Ca-gluconate, 2.4 mM K2HPO4,0.4 mM KH2PO4,100 pM amiloride; (iv) HPBR (Cl" free) supplemented with 100 pM amiloride, 200 pM 8-cptcAMP, 10 pM forskolin; (v) HPBR (CI" free) supplemented with 100 pm amiloride, 200 pM 8-cpt-cAMP, 10 pM forskolin, 100 pM UTP; and (vi) HPBR. These conditions are used to create a chemical driving force by which changes in CI" permeability were assessed following cAMP, and UTP agonist stimulation. Millivolt recordings were taken by computer-assisted data link every 5 sec. To determine the optimal DNA:lipid ratio for lipofectamine transfections, 60, SO, 90, 100, and 120 pg of p/3aCFTR DNA were complexed with 60 or 80 pg of lipofectamine prior to gene ttansfer into xenografts (at least two measurements were made for each concenttation). The optimal ratio for ttansfections was determined in CF xenografts by assessing the level of 8-cpt-cAMP/forskolin-stimulated changes in ttansepithelial PD under CI" secretory conditions. Measurements of UTP-simulated CI" secretion through the Ca"'"-activated CI" channel were used to control for the integrity of the epithelium. Initial time course studies with liposome-mediated CFTR gene ttansfer at 24,48, and 72 hrs demonsttated the highest level of correction in 8-cpt cAMP/Forskolin induced changes in transepithelial PDs at 48 hrs post-ttansfection. Hence, all ttansepithelial PDs in subsequent stadies were assessed at 48 hrs post-transfection or infection.
Assessment of gene transfer using recombinant adenovirus
The level of recombinan adenovims-mediated gene transfer was assessed by histochemical staining for Alkphos and immunofluorescence for CFFR protein expression. Alkphos stain-ing procedures were performed as previously described for the xenograft model system using heat inactivation at 65°C for 30 min to inactivate endogenous Alkphos prior to staining of the heat-resistant mammary gland Alkphos (the marker gene encoded in Ad.CMV/3aA//tp/!0i) (Engelhardt et al, 1995) . An important note is the fact that Alkphos protein localizes to the apical membrane of ciliated cells and may give the appearance of lower levels of infection due to this specific localization pattem. Indirect CFTR immunofluorescent staining was performed on xenograft sections (6 pm) fixed in methanol (-20°C) for 10 min followed by air drying. Sections were blocked with phosphate-buffered saline (PBS) containing 20% donkey semm (DS) for 30 min at room temperatare, then incubated for 90 min in 1.5% DS/PBS containing a 1/250 dilution of a monoclonal anti-hCFTR antibody generated against a carboxy-terminal peptide of human CFFR (Genzyme Inc.). Following staining, sections were washed in three changes of 1.5% DS/PBS for 8 min, each followed by incubation in 1.5% DS/PBS containing 5 /u,g/ml of a donkey anti-mouse fluoroisothiocyanate (FITC)-conjugated secondary antibody for 30 min. Finally, sections were washed and coverslipped in Citifluor antifadent.
Studies determining the frequency of recombinant adenoviral gene ttansfer to various cell types utilized an Ad.CMV/3a/-acZ vector as previously described (Engelhardt et al, 1993) . Identification of the various cell types was based on the following morphologic criteria in GMA thin sections: ciliated cell, the presence of apical cilia; basal cell, cuboidal-appearing cell of high nuclear to cytoplasmic ratio with nuclei in the lowest layer of epithelium, direct contact with the basal lamina, and no luminal contact; goblet cells, the presence of mucous granules as visualized under Nomarski optics; nonciliated columnar cells, the absence of cilia and secretory granules but with an apical boundary at the luminal surface; and intermediate cells, cells adjacent to the basal lamina with cytoplasm extending upward into the epithelium but not contacting the luminal surface. The relative infection efficiency of ciliated cells, basal cells, goblet cells, and intermediate cells was quantitated by counting at least 30 independent fields from four xenografts infected with 5 X 10'° pfu of vims. Baseline determination of cell frequencies was determined in the same xenografts by similarly quantitating all cells regardless of ttansgene expression. Studies for quantification utilized Ad.CMV^a/acZ vims due to the even distribution of transgene expression throughout the cytoplasm. However, for functional stadies of mucus sulfation, Alkphos recombinant vims was used due to the potential effects of )3-galactosidase (;3-Gal) on mucin glycosylation.
Assessment of cationic liposome-mediated gene transfer
Histochemical staining of lipofectamine:DNA-ttansfected xenografts was incapable of detecting ttansgene expression from either Alkphos or LacZ encoding plasmids (data not shown). To this end, we performed experiments using two altemative methods of detecting gene ttansfer including reverse transcription polymerase chain reaction (RT-PCR) for CFTR mRNA following transfection with p/SaCFTR and detection of luciferase activity following transfection with a pGL3(RSV-luciferase) constmct. For RT-PCR detection of CITR ttansgene expression, we amplified a 600-bp fragment spanning the 3' end of the CFTR cDNA and the p^aCFIR bovine growth hormone (bGH) polyadenylation sequences. This amplified product included a portion of the heterologous bGH poly(A)tail and served to prevent amplification of endogenous CFTR mRNA. Total RNA was prepared from pSV2Neo-and p/SaCFTR-ttansfected xenografts using a Qiagen (Santa Clarita, CA) RNeasy kit. At 48 hr post-transfection, human airway epithelial cells were lysed in situ and washed out of the xenograft with a lysis buffer included in the kit. Total RNA was then exttacted following the manufacturer's insttnctions. In an effort to purify mRNA from contaminating plasmid DNA, total RNA bound to the RNeasy membrane was washed extensively for a total of eight times. To eliminate possible plasmid contamination further, all RNA samples were treated witii RNase-free DNase for 15 min at 37°C before RT reactions were performed. Reverse transcription was carried out with a Clontech (Palo Alto, CA) first-strand cDNA Synthesis Kit. Approximately 0.5 pg of total RNA was reverse-transcribed using 200 units MMLV (Moloney murine leukine vims) reverse ttanscriptase in the presence of 20 pmol oligo(dT)i8 primers. A 5-p\ amount of the RT reaction mixture was used as a template for PCR amplification using primers EL284 (5'-GCAGTTGATGTGCTTGGC-T AG ATC) and EL285 (5'-AAAGGGAACAAAAGCTG-GTACCGG). The identity of RT-PCR products was determined by Southem blotting. The PCR products were separated on a 1% TAE-agarose gel, ttansferred onto nylon membranes, and hybridized to a cDNA probe corresponding to a region intemal to the amplified fragment. Hybridization was carried out ovemight with ^^P-labeled cDNA (>3 X 10* dpm/ml) at 42°C in a solution containing 50% deionized formamide, 6X SSPE, 5X Denhardt's solution, 200 /xg/ml salmon sperm DNA, and 0.5% SDS. The membranes were washed with increasing stringency until the background radioactivity level was sufficientiy low. The final wash was performed at 6S°C for 20 min in a solution containing O.IX SSPE and 0.1% SDS. Autoradiography was performed at -S0°C for 4 hr on Kodak BioMax film using intensifying screens.
To determine the efficiency of liposome-mediated ttansgene expression, human airway xenografts were ttansfected with either a luciferase-expressing plasmid (pGL3) or a conttol plasmid (pSV2Neo). Luciferase assays were performed in a TD-20/20 Luminometer (Tumer Designs) under dim light using a Promega (Madison, WI) Luciferase Assay Kit. Briefly, airway epithelial cells were lysed in situ and washed out of the xenograft with 200 p\ of lysis buffer included in the kit. The luciferase assay was initiated by mixing IO-/1I samples witii 40 p\ of reconstituted luciferase assay reagent so that die final reaction mixture contained 16 mM Tricine, 0.S6 mM (MgC03)4Mg(OH)2-5H20, 2.13 mM MgS04, 0.08 mM EDTA, 26.6 mM dithiottireitol (DTT), 216 pM coenzyme A, 376 pM luciferin, and 424 pM ATP. Typically, luminescence readings were recorded by a computer datalink for 10 readings of 10 sec each in the Luminometer witii a sensitivity level of 100%.
Purification and analysis of large-molecular-weight secreted mucin from bronchial xenografts Experiments analyzing the level of sulfation in secreted mucin were initiated at 72 hr following infection witii recombinant adenovimses and 48 hr post-transfection wifli lipofecta-mine:DNA mixtures. At these time points, ttansfected xenografts were metabolically labeled with both Na2S^^04 (25 /xCi) and [^H]-glucosamine (25 pCi) for 72 hr by instillation of radioisotopes tn HPBR solution. Metabolically labeled cmde secretions were harvested by irrigation with 1 ml of HPBR and frozen on dry ice. All analyses were performed from paired CF xenografts implanted in the same mouse, which was infected/ttansfected with control or CFTR vectors. Cmde mucous secretions were purified by two rounds of gel filtration using a previously described protocol (Zhang et al, 1995) . Briefly, xenograft secretions were reduced and denatured by dialysis against 10 mM Tris pH S.O, 5 mM DTT, and 8 M urea for 24 hr followed by factionation in the same buffer on a Sepharose CL-6B column (1 X 60 cm). The void volume peaks were pooled, carboxymethylated under nittogen with 15 mM iodoacetamide followed by dialysis and digestion with 240 units/ml DNase and 75 units/ml of bovine testicular hyaluronidase (Type VI; Sigma) for 6 hr at 37°C. This fraction was repurified on a second gel filtration. Sepharose CL-6B column (2 X 125 cm) in 10 mM Tris pH 8.0, 5 mM DTT, and 8 M urea. Void volume peaks included hyaluronidase-insensitive mucous glycoprotein of a molecular weight of greater than 5 million daltons. The extent of sufation was assessed as ratio of ^^S/^H-glucosamine dpm counts. Statistical comparisons were performed by Student's f-test using both paired and unpaired analyses. Significance was given to p values of less than 0.05. Since the absolute values of ^^S incorporation varied from experiments performed on different days due to different specific activities of radiolabeled precursors, all analyses in this report used only matched sets of either CF versus non-CF or conttol versus CFTR vectors that were transplanted in the same mouse. This assured that the mean values of ^^S/^H-glucosamine for all experiments could be compared direcdy. OF Ad. CMV|3aAlkphos   FIG. 1 . Complementation of CF defects in CI" permeability using recombinant adenovirus. Functional complementation of CI" permeability defects following a single administration (5 X 10'° pfu/xenograft) of Ad.CMWI3a.CFTR or Ad.CMV/3a Alkphos recombinant adenovims to CF xenografts is compared to that of CF and non-CF uninfected xenografts. Transepithelial potential difference was assessed using a series of buffer perfusions: (i) HPBR (145 mM CI); (ii) HPBR, 100 pM amiloride; (iii) HPBR (CI" free), 100 pM amiloride; (iv) HPBR (CI" free), 100 pM amiloride, 200 pM 8-cpt-cAMP, 10 pM forskolin, (v) HPBR (CI" free), 100 pM amiloride, 200 pM Scpt-cAMP, 10 pM forskolin, 100 pM UTP, and (vi) HPBR (145 mM CI). Arrows mark the buffer changes in order from left to right. Changes in the ttansepithelial PD following cAMP stimulation are proportional to the extent of CFTR correction whereas changes in transepithelial PD induced by UTP indicate CI" secretion through the Ca"*"-activated chloride channel (serve to control for the electrical integrity of the surface airway epithelium).
RESULTS
Functional complementation using recombinant adenovirus
Recombinant adenovirus was used to evaluate the complementation profile of CI" permeability and mucous sulfation defects in CF xenografts. Infection of CF xenografts with 5 X 10'° pfu of recombinant Ad.CMV)3aCFTO was capable of correcting defects in cAMP-inducible Cl~ permeability to a level of 91 ± 14% of that seen in non-CF xenografts (Fig. 1 ). In contrast, infection of xenografts with 5 X 10'° pfu of Ad.CMV/SaAlkphos generated no change in ttansepithelial PD profiles as compared to uninfected CF xenografts (Fig. 1) . Studies utilizing single dose delivery of 5 X 10'° pfu of recombinant Ad.CMV)3a/acZ to xenograft airways demonsttated an average ttansduction of 11 ± 1% (Fig. 2) . With die exception of basal cells, which were poorly infected, tiie ttansgene expression was evenly disttibuted among various cell types in the airway, including ciliated, nonciliated columnar, intermediate, and goblet cells. These studies confirmed previous reports with this same recombinant adenoviral vector, which demonsttated complete correction of cAMP-inducible CI" permeability in CF xenografts at levels of infection between 5 and 10% (Goldman et al, 1995) . Such findings also support previous in vitro work suggesting that electrically tight epithelial monolayers pass CI" through gap junctions, thus allowing for complementation of bulk CI" flow when 5-6% of epithelial cells overexpress the CFTR transgene (Johnson et al, 1992) . Despite the high efficiency by which recombinant CFTR adenovirus-corrected defects in CI" secretion, this single infection protocol did not significantly alter the mucous sulfation profile of CF xenografts (^'S/^H-glucosamine ratio = 0.29 ± 0.06) as compared to uninfected CF xenografts (^'S/^H-glucosamine ratio = 0.32 ± 0.07). Complete correction in mucous sulfation would be reflected as a decrease in the ^^S/^H-glucosamine ratio to a level found in non-CF xenografts (^^S/^H-glucosamine ratio = 0.16 ± 0.04). Since on average only 16% of goblet cells were transduced in these studies, we altered the infection protocol of xenografts to include three sequential infections with recombinant adenovirus. With this modified infection protocol, Ad.CMV)3aA/fcp/!o.s-infected xenografts demonsttated nearly complete ttansduction in all columnar airway cells, as evident by histochemical staining for Alkphos protein (Fig. 3A) . The lack of Alkphos staining in confrol Ad.CMVjSaCFTR-infected xenografts demonsttate the specificity of the histochemical staining procedure. It should be noted that the Alkphos protein localizes to the apical surface of ciliated cells, hence the lack of cytoplasmic staining should not be confused with a lack of gene ttansfer in this cell type. In conttast, recombinant Alkphos protein localizes to the cytoplasm of goblet and nonciliated columnar cells, as evident by the stiiped pattem of staining (Fig.  3A) . When xenograft sections were stained with a monoclonal anti-hCFTR antibody generated against a carboxy-terminal peptide of human CFTR, apical staining was seen around the entire lumen of xenografts infected with Ad.CMVpaCFTR (Fig.  3C,D) but not Ad.CMVjSaAlkphos (Fig. 3E,F) . It should be noted that the level of endogenous CFTR is much lower than that produced by recombinant adenovims and is undetectable by the immunocytochemical procedures used in this report. Studies evaluating the complementation of sulfation defects at this high level of infection compared the ^^S/^H-glucosamine ratios of purified secreted mucous fractions between Ad.CMV paAlkphos-and Ad.CMV/SaCFTR-infected CF xenografts (n = 7 pairs). Results from this analysis (Fig. 3G ) demonsttated that CFTR expression is capable of reducing mucous 3^S/^H-glucosamine ratios from a mean of 0.245 ± 0.04 in Ad.CMV/3aA/fcp/!0i-infected xenografts to 0.144 ± 0.037 in Ad.CMV^aCFT/f-infected xenografts {n = l,p< 0.03, paired Student's f-test). Because CF xenografts have a two-fold higher level of mucous sulfation as compared to non-CF xenografts (Zhang etal, 1995) , this 41% reduction in ^'S/^H-glucosamine ratio demonstrates near complete correction of mucous sulfation defects with recombinant CFTR adenoviruses. Paired analysis of Ad.CMV)3aA/Ap^oi/Ad.CMV/3aCFr/?-infected xenografts demonsttated a slightiy higher level of correction with sulfation levels 2.3 ± 0.6-fold higher in Ad.CMV/3a Alkphos-as compared to Ad.CMV/SaCFTR-infected CF xenografts (p < 0.03, n = 7). In summary, although single-dose administration of recombinant CFTR adenovims was incapable of correcting mucous sulfation defects seen in CF airways, repeated infection that achieved nearly complete transduction of goblet cells was capable of reversing the increased sulfation levels seen in CF airways. These studies underscore the different complementation profiles of CF-associated mucous sulfation and cr permeability defects using recombinant CFTR adenoviral vectors.
Functional complementation using cationic liposome.DNA complexes Studies evaluating liposome-mediated gene transfer in xenografts used plasmid DNA complexed with lipofectamine. Two plasmid DNA constmcts were used, p)3aCFTR and pSV2Neo (as a negative control for nonspecific effects associated with liposome-mediated gene transfer). Plasmid DNA was purified through two rounds of CsCI density centiifugation and tested negative for bacterial endotoxin. Because the level of gene transfer with liposomes was below the levels of detection with traditional histochemical and immunocytochemical techniques used to detect gene expression, we optimized the DNA:lipid ratio by assessing complementation of CF-associated defects in cAMP-induced CI" permeability using transepithelial PD (data not shown). The ttansepithelial PD profile from pSV2Neo-transfected CF xenografts was indistinguishable from that prior to gene transfer (Fig. 4A,B) . However, ttansfection with lipofectamine: p)3aCFTR produced a low level of cAMP/forskolin-induced transepithelial PD as compared to non-CF xenografts (Fig. 4A,B) . Furthermore, the time course of correction following p/3aCFTR transfection was highest at 48 hr post-ttansfection and diminished significantly by 72 hr (Fig. 4C) . The optimal DNA:lipid ratio for these stadies was 90 pg DNA:60 pg lipofectamine. The average delta mV change in response to cAMP/Forskolin under these optimal conditions was 0.0 ± 0.09 mV for pSV2Neo-and 0.69 ± 0.22 mV for pPaCFTR-transfected CF xenografts (V = 12) (Fig. 4D ). This change in response to cAMP/Forskolin represents an approximately 7.4 ± 2.4% correction in comparison to non-CF xenografts (Fig. 4) . As a control for the integrity of the epithelium following liposome-mediated gene ttansfer, the non-CFTR CI" response induced by UTP was assessed in all xenografts. UTP-stimulated CI" secretion was unaffected by liposome-me-FIG. 3. Complementation of mucous sulfation defects using recombinant adenovims. CF xenografts pairs were infected sequentially three times with either 5 X 10'° pfu of Ad.CMV/SaCFTT? or Ad.CMVjSaAlkphos. Histochemical detection of Alkphos gene transfer in stained frozen sections is shown for Ad.CMV^aAlkphos-'miecttd xenografts (A) and Ad.CMV/SaCFT/f-infected xenografts (B). Similarly, frozen sections from xenografts infected with Ad.CMV/SaCFT/? (C and D) and Ad.CMVpaAlkphos (E and F) were evaluated for CFTR protein expression by immunofluorescent staining using a monoclonal anti-hCFTR antibody generated against a carboxy-terminal peptide (Genzyme Inc.). C and E represent Nomarski photomicrographs whereas D and F are FITC channel immunofluorescent images. Nearly complete uniform CFTR staining across the apical membrane of surface airway epithelial cells (SE) can be seen in Ad.CMV/SaCFTR-infected xenografts (arrows in C and D). In contrast, apical staining of airway epithelial cells was absent in Ad.CMV/SaA/^p/joi-infected xenografts (E and F). Background staining below the basal membrane (BM) is caused by nonspecific adherence of the anti-mouse secondary antibody to mouse-derived tissue in xenograft (marked by asterisks) and is present in sections treated with secondary antibody alone (data not shown). The effects of recombinant adenoviral CFTR expression on the level of mucous sulfation from CF-infected xenografts were analyzed in CF xenograft pairs (ttansplanted within a single mouse) infected serially three times with either recombinant Ad.CMVjSa Alkphos or Ad.CMVjSaCFT/?. Purified metabolically labeled large-molecular-weight mucin fractions were compared between infected pairs of xenografts for the ratio of ^^S/^H-glucosamine (Panel G). The mean (±SEM) ^^S/-^H-glucosamine dpm ratios are shown at the borders of each graph for Alkphos-and CFTR-infected xenografts. Statistical comparison using a paired Student's r-test reveals significant differences in the extent of mucous sulfation between Ad.CMVpaAlkphos-and Ad.CMVSaCFT/f-infected xenografts (p < 0.03, n = 7). These experiments utilized four independent CF tissue samples for generating xenografts. (Fig. 4D) . These results demonsttate that the xenograft epithelium remained electrically tight throughout the experiments and served as a conttol for the integrity of the xenograft epithelium when cAMP/Forskolin responses were absent.
In an effort to confirm that CFTR was expressed following liposome-mediated plasmid transfection, we performed RT-PCR analysis for CFTR mRNA on epithelia harvested from pSV2Neo-and pjSaCFTR-ttansfected CF xenografts. These results are summarized in Fig. 4E and demonsttate detectable CFTR mRNA only in pjSaCFTR-transfected epithelia. The absence of PCR product in pSV2Neo-ttansfected xenograft confrnns the specificity of PCR primers for recombinantiy derived CFTR mRNA. Furtiiermore, RT-rainus conttols of p;8aCFTR-ttansfected xenografts confirm the lack of plasmid background signal. Attempts to localize liposome-mediated gene expression histochemically using Alkphos and LacZ plasmids were unsuccessful due to the low level of gene expression (data not shown). However, more sensitive reporter assays using luciferase plasmids have demonsttated liposome-mediated transgene expression at levels 15-fold above that of pSV2Neo conttols (Fig. 5A ). In summary, these optimal ttansfection conditions demonsttated a lack of substantial correction of CI" secretory defects in a setting of low-level gene ttansfer. Studies evaluating correction of mucous sulfation defects in CF xenografts with lipofectamine ttansfection compared the extent of sulfation in purified secreted mucous fractions between pSV2Neo-and p/3aCFTR-transfected xenografts (« = 6 pairs). In these stadies, xenografts were transfected 48 hr prior to metabolic labeling with Na2S^^04 and [^H]-glucosamine. Results from mucous sulfation analysis (Fig. 5B ) demonsttated that CFTR transfection was capable of reducing mucous ^^S/^H-glucosamine ratios from a mean of 0.253 ± 0.034 in pSV2Neo-ttansfected xenografts to 0.150 ± 0.047 in p/3aCFTR-ttansfected xenografts (n = 6, p < 0.007, paired Stadent's Mest). These findings demonstrate a 41% reduction in the mean mucous ^^S/^H-glucosamine ratio following ttansfection with CFTR-containing liposomes as compared to pSV2Neo-transfected conttols. Paired analysis of pSV2Neo/ p/3aCFTR-ttansfected xenografts demonstrated a slightly higher level of correction with sulfation levels 2.4 ± 0.7-fold higher in pSV2Neo-as compared to p/3aCFTR-ttansfected CF xenografts. Such a change is well within the physiologic range of conection associated with a two-fold increase in CF mucous sulfation as compared to non-CF. In summary, the low level of cationic liposome:CFTR DNA-mediated gene ttansfer produced inefficient complementation of CI" permeability in a setting of full conection of mucous sulfation defects within CF airway epithelium. These findings are in stark conttast to re-FIG. 4. Complementation of CI" permeability defects in CF xenografts using cationic liposome-mediated gene ttansfer. Transepithelial PD profiles from CF xenografts ttansfected with either lipofectamine:pSV2Neo or lipofectamine:pjSaCFTR were compared to that of uninfected CF and non-CF xenografts. Tracings in A-C demonsttate changes in ttansepithelial PD using a series of perfused buffers including: (i) HPBR (CI" free), 100 pM amiloride, (ii) HPBR (CI" free), 100 pM amiloride, 200 pM 8-cpt-cAMP, 10 pM forskolin, (iii) HPBR (CI" free), 100 pM amiloride, 200 pM 8-cpt-cAMP, 10 pM forskolin, 10() pM UTP, and (iv) HPBR (145 mM CI). Anows mark die buffer changes in order from left to right. (A) Typical ttansepitiielial PD profiles from both CF (left) and non-CF (right) xenografts. Two examples of ttansepithelial PD profiles 48 hr following lipofectamine:DNA gene transfer are given for pjSaCFTR-(left) and pSV2Neo-(right) ttansfected CF xenografts in B. The typical time course of cAMP inducible CI" secretion following transfection with p^aCFTR is given in C which analyzed die same xenograft at 48 hr (left) and 72 hr (right) post-ttansfection. The mean AmV responses (±SEM n = 12) to cAMP/forskolin and UTP for xenografts tt^sfected with p^aCFTR and pSV2Neo lipofectamine:DNA complexes are given in D. RT-PCR analysis for CFTR mRNA was performed on p^aCFTR-and pSV2Neo-ttansfected xenografts using pmners specific for the 3'-untranslated region of the human p^ilrr^'"' (E). The anow marks the appropriate-sized ?^rf K , *[^Sment, which hybridized to a ttansgene specific -P-labeled probe on Southem blot only in p/3aCFTR transfected xenografts. combinant adenovirus, which was capable of more efficientiy conecting CI" permeability as compared to mucous sulfation defects.
DISCUSSION
Two widely investigated pathophysiologic defects in CF include alterations in the biochemical properties glycoproteins and the absence of cAMP-inducible CI" permeabilities. Such defects in secreted mucus suggest that goblet cells in the airway may be targets for gene therapy in CF. In contrast, the target cell types for conection of CI" permeability defects likely represents a more diverse range of columnar epithelial cell types that contact the lumenal surface of the airway (potentially including goblet, ciliated, and nonciliated columnar cells). To this end, we hypothesized that the complementation profile of mucus-processing defects may be quite different form that of CI" conductance. Such complementation profiles likely reflect multiple factors including: (i) the percentage of epithelial cells transfected, (ii) the epithelial cell types transfected, and (iii) the level of ttansgene expression per ttansfected cell. When comparing the complementation of CV secretory defects as measured by cAMP/Forskolin inducible changes in transepithelial PD, recombinant adenovirus demonstrated a much higher efficiency of correcting this functional endpoint than cationic liposomes (Fig. 6B,C) . In contrast, when complementation of mucous sulfation defects were analyzed, cationic liposome-mediated gene transfer appeared to be much more efficient than recombinant adenovirus in reversing the increased level of sulfation seen in CF (Fig. 6 ). Repetitive infections with recombinant CFTR adenovims were required to achieve complete correction of mucous sulfation defects (Fig. 6 ). Such findings suggest that recombinant adenovims is more effective at complementing CI" secretory defects whereas liposome-mediated gene ttansfer was more efficient in conecting mucous sulfation defects.
The different complementation profiles of CI" secretory and mucous sulfation defects with recombinant adenovims-mediated CFTR gene ttansfer reflect the ability of this vector to express a high level of ttansgene in an infrequent number of cells (11 ± 1%) following single infection. Such conditions have previously demonstrated full conection of bulk CI" conductance abnormalities across CF airway epithelium by a mechanism that likely includes intercellular CI" permeability through gap junctions (lohnson et al, 1992) . However, these same conditions that ttansduced 11 % of the total epithelium with high levels of ttansgene expression were only capable of targeting 16% of the goblet cells necessary for complementation of mucus-processing defects. This shortcoming of recombinant adenovims could be overcome by multiple infections that provide more complete complementation of mucous sulfation defects by increasing the percentage of goblet cells infected (Fig. 6A) . 6 . Summary of complementation profiles for mucous sulfation and CI" permeability defects using recombinant adenovims and liposome-mediated gene transfer. Cumulative results of ^^S/^H-glucosamine ratios from three groups of xenograft pairs analyzed are shown in A for (i) CF vs non-CF (n = 13); (ii) CF xenografts infected three times with either recombinant Ad.CMVPaAlkphos or Ad.CMVfiaCFTR (n = 7); and (iii) CF xenografts ttansfected with either pSV2Neo:lipofectamine or p/3aCFTR;lipofectamine (n = 6). Results are shown as the mean ±SEM raw ^^S/^H-glucosamine dpm ratio. Statistical comparisons were performed using the paired Student's Mest for each of the groups: CF versus non-CF (p < 0.004), Ad.CMVfiaAlkphos versus Ad.CMV^aCFT/f (p < 0.003), and pSV2Neo vs p)3aCFTR (p < 0.007). Differences in the complementation profile between recombinant adenovims and liposomes are shown in B and C for defects in cAMP-induced CI" permeability and mucous sulfation. B shows the AmV change in cAMP-inducible transepithelial PD as compared to the raw dpm ratio of ^^S/^H-glucosamine for purified mucin in each of the labeled xenograft categories. The percent conection in AmV(cAMP) and mucous sulfation was calculated by comparison of non-CF xenograft values to those from Ad.CMV;8aCFTR-or p^aCFTR-infected/ttansfected CF xenografts (C). At least six independent xenografts were used to determine the mean (±SEM) for all data points in this figure.
In conttast to recombinant adenovims, the complementation profiles for cationic liposome-mediated gene transfer demonstrated inefficient conection of CI" conductance defects in a setting of fully conected defects in mucous sulfation (Fig. 6) . We interpret this finding to reflect the ability of cationic liposomes to transfect a large proportion of epithelial cells (hence efficiently targeting goblet cells) with low levels of transgene expression. Such levels of ttansgene expression, which appear to be incapable of significantiy altering the electrophysiologic characteristic of the epithelium, have significant effects on mucous glycoprotein sulfation. These results predict that the level of inttacellular CFTR required for complementation of glycoprotein-processing defects may be much lower than diat needed for movement of CI" across the airway epithelium. Such predictions are supported by work that suggests tiie number of CFTR molecules needed for endosomal acidification may be quite low (Barasch et al, 1991; Al-Awqati et al, 1992) . One obvious limitation of the present liposome stady is die inability to quantitate accurately the overall percentage and types of cells transfected with cationic liposomes due to undetectable levels of ttansgene expression by ttaditional histochemical methods. However, stadies evaluating more sensitive assays such as RT-PCR for CFIR mRNA and luciferase expression, confinned that transgenes were expressed at low levels in the airway epithelium following liposome-mediated ttansfection. Although we interpret the complementation profile of cationic liposomes to reflect a low level of transgene expression in the majority of epithelial cells in the airway, an altemative interpretation of this data might include a preference of goblet cell gene ttansfer with liposomes. However, because transfection with cationic liposomes are thought to be driven by nonspecific interactions with target cell membranes and no evidence to date has demonstrated cell type specificity of transfection, this altemative mechanism is unlikely.
In summary, our results demonstrate vector specific efficacies that are dependent on the sunogate marker used for assessing complementation (i.e., CI" permeability or mucous sulfation) and differences in the mechanisms by which recombinant adenovims and cationic liposomes transfect airway epithelia. One interesting implication of these findings is FIG. 7. Vector-specific complementation profiles of mucous sulfation and CV permeability defects in CF airway epithelia reflect the endogenous cell-type-specific partitioning of CFTR expression. The normal endogenous expression pattem of CFTR protein is depicted in A (Engelhardt et al, 1992 . Expression of CFTR protein is denoted by yellow dots. Cell types are marked as: B, basal cells; C, ciliated cells; NC, nonciliated columnar cells; I, intemiediate cells; and G, goblet cells. B depicts the observed expression pattem of CFTR following a single-dose administration of recombinant CFTR adenovims with the hypothesized mechanisms for full conection of CV secretion by intercellular CI" permeability through gap junctions (lohnson et al, 1992) . In contrast, tiiis patterning of expression within a minority of airway cells does not conect mucous sulfation defects due to the lack of targeting to goblet cells. C schematically represents the hypothesized mechanisms of liposome-mediated gene transfer with low levels of transgene-derived CFTR expression in the majority of airway cell types. This low level of expression efficientiy conects inttacellular defects in goblet cell mucous sulfation. However, this low level of liposome-mediated CFTR expression in columnar cell types is incapable of mediating CI" secretion at levels seen in non-CF or CF airways ttansduced with recombinant CFTR adenovims. Vectors are denoted by yellow lines and circles within nuclei for recombinant adenovims and plasmids, respectively. reflected in the pattem of vector-mediated CFTR expression as compared to that of endogenous CFTR expression. Endogenous CFTR expression pattems in the airway are extremely heterogeneous at both the level of gene expression and the cell types that express CFTR. For example, an infrequent nonciliated columnar cell type that expresses very high levels of endogenous CFTR in the airway exists in an abundance of 1-10% of the total surface airway epithelial cells (Fig. 7A) . In conttast, ciliated cells express low levels of CFTR protein not detectable by immunocytochemical methods. Given the fact that recombinant adenovims-mediated gene ttansfer minors expression in the infrequent nonciliated columnar cells that express high levels of CFTR, one might anticipate that this cell type functions to facilitate bulk CI" secretion in a manner similar to that seen with recombinant CFTR adenovims following a single infection (Fig. 7B) . In conttast, if ciliated cells are transduced at low levels with liposome-mediated gene ttansfer, this also minors the endogenous pattem of expression in this population of cells (i.e., below the sensitivity of immunocytochemical detection). Because CFTR liposomes poorly complemented CI" secretory defects, one might speculate that the endogenous level of CFTR expression in ciliated cells might not significantly contribute to CI" secretion ( Fig. 7) . Last, the endogenous low level of CFTR expression in goblet cells is supported by findings of efficient complementation of mucous sulfation defects at very low levels of ttansgene expression. Taken together, these results that demonsttate vector specific complementation of CI" permeability and mucous sulfation defects reflect the ability of recombinant adenovims and cationic liposomes to reconstitute one, but not all, cellular components associated with endogenous CFTR expression pattems in the airway (Fig. 7) .
It is presently unknown how the diverse expression pattems of endogenous CFTR coordinate the regulation of electtolyte permeabilities in the airway. Findings in the present study that demonsttate different extents of CI" secretory capacity based on the level and cellular pattem of CFTR gene expression suggest that cellular partitioning may in part be important in regulating electtolyte permeabilities in the airway. Such mechanisms of cellular partitioning of Cl^ and Na"*" ttansport have been previously described in amphibian skin (Larsen, 1991) . In frog skin, mitochondria-rich cells composing approximately 1% of the cells in this epidermal layer are the sole route for CI" conductance across this epithelia. Interestingly, the route of transepithelial CI" fluxes in amphibian skin through mitochondria-rich cells also appear to be conttolled by a cAMP-dependent pathway (Katz et al, 19S6; Larsen, 1991) . Such amphibian epidermal models have conclusively demonstrated that CI" and Na'^ conductance pathways are through distinct cellular populations (Na""" absorption through the majority of epidermal cells and CI" absorption through the subset of mitochondria-rich cells). Hypotheses for cell-type-specific regulation of Na^ and CI" conductance have also been suggested in bovine tracheal epithelium (Langridge-Smith, 1985 , 1986 .
Our results evaluating the complementation of mucous sulfation defects using recombinant CFTR adenovims and CFTR liposome-mediated plasmid gene transfer are the first direct genetic evidence that increased sulfation seen in CF auways is due to a lack of CFTR gene function. Furthermore, the vectordependent complementation profiles of CI" permeability and mucous sulfation defects suggest that die choice of sunogate markers for conection in gene therapy of CF will likely need to be tailored to the particular vehicle being analyzed. Such differences underscore the vector-dependent mechanisms of gene transfer to airways and their ability to target cell types capable of abrogating the pathologic phenotype in question.
